Geoffrey C. Hsu brings an unusual combination of medical training from Harvard Medical School and healthcare investment banking experience to his role as a long-tenured public equity specialist at OrbiMed, where he has been a portfolio manager since 2005. He also serves as Portfolio Manager for The Biotech Growth Trust, a London-listed investment trust, giving him a cross-border perspective on biotech investing and making him a regular public communicator on biotech market cycles. Geoffrey C. Hsu brings an unusual combination of medical training from Harvard Medical School and healthcare investment banking experience to his role as a long-tenured public equity specialist at OrbiMed, where he has been a portfolio manager since 2005. He also serves as Portfolio Manager for The Biotech Growth Trust, a London-listed investment trust, giving him a cross-border perspective on biotech investing and making him a regular public communicator on biotech market cycles.